Americans spend more on prescription drugs than any other nation. This fact is driven not just by volume but by staggering costs. Unlike in Europe, the US government has historically refrained from directly intervening in price setting. While modest changes under then-President Joe Biden offered some relief for seniors, his successor, Donald Trump, has vowed to aggressively slash US drug…
Tag: US politics
-
Pfizer Drug Pricing Deal Sees Stocks Soar
In a move heralded by President Donald Trump as a monumental victory for American consumers, pharmaceutical giant Pfizer has agreed to a deal that promises to slash the prices of some of its drugs. However, the market’s reaction has told a very different story. This reaction raises questions about the actual impact of the agreement on the firm’s bottom line…
-
HHS Restructuring Plan Blocked by Federal Court
A US Federal Appeals Court has maintained a block on the Trump administration’s ambitious and controversial plan to overhaul the Department of Health and Human Services (HHS). This move would have resulted in 10,000 job losses. Additionally, it would have caused a significant restructuring of key public health agencies. A three-judge panel of the Boston-based 1st US Circuit Court of…
-
Republicans Rein in Kennedy During High-Stakes Hearing
In a significant break with the Trump administration, a high-ranking Republican senator is set to publicly scrutinise the controversial actions of Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. This move indicates an effort by Republicans to rein in Kennedy amid growing controversies. The move signals a growing effort within the GOP focused on reining in Kennedy and…
-
Children’s Lives at Risk as US Proposes Slashing Funds for Gavi
In a move putting children’s lives at risk, the US government has announced its intention to cut funding for Gavi, the Vaccine Alliance. It is a key organisation credited with saving millions of lives through childhood immunisation. The decision comes at a critical time, as rising vaccine hesitancy contributes to a resurgence of preventable diseases like measles worldwide. The proposed…
-
Florida’s ‘Vaccine War’ Sparks Outrage and Debate
Florida is becoming the new epicentre of America’s “vaccine wars.” This follows Governor Ron DeSantis’s announcement to eliminate all vaccine mandates for schoolchildren. The plan has ignited immediate and fierce opposition from political rivals and the medical community. The move, if successful, would make Florida the largest US state to dismantle long-standing public health requirements for immunisations. The controversial proposal…
-
Lower Pharmaceutical Prices: Trump’s Bold Ultimatum
President Donald Trump has dramatically escalated his campaign against high medicine costs. He issued a stark ultimatum to 17 of the world’s leading pharmaceutical firms. In a move aimed at achieving lower pharmaceutical prices, the President demanded that they slash prices for American consumers. He wants them to match what is paid in other developed nations, setting a 60-day deadline…
-
Trade Tariffs and Their Impact on Pharmaceuticals
The pharmaceutical industry is bracing for a significant financial blow. Analysts forecast costs of between $13 billion and $19 billion following a new transatlantic trade deal. This deal will subject branded medicines to a hefty 15% tariff. Officials confirmed the landmark trade agreement between the European Union and the United States on Sunday. It marks the end of the historic…
-
Trump targets drug costs in sweeping executive order
US President Donald Trump has signed a wide-ranging executive order. It targets drug costs by directing pharmaceutical companies to lower their prices. The goal is to align with rates paid in other developed countries. This executive order marks a clear initiative where Trump targets drug costs. It fulfills a key campaign promise. The move was met with scepticism from analysts…
-
US foreign aid pause threatens global HIV treatment
The World Health Organisation (WHO) has issued a stark warning regarding the impact of the Trump administration’s decision to pause US foreign aid. This pause has “substantially disrupted” the supply of life-saving HIV treatment in eight countries, placing millions at risk. According to the WHO, Haiti, Kenya, Lesotho, South Sudan, Burkina Faso, Mali, Nigeria, and Ukraine are facing imminent shortages…